Skip to main content

personalized medicine Archives

Grant creates center for maternal, pediatric precision therapeutics

Sep. 17, 2021—Vanderbilt University Medical Center has been awarded a five-year, $6 million grant from the National Institutes of Health to serve as a center of excellence for Maternal and Pediatric Precision in Therapeutics.

Read more


VUMC team to test personalized acute heart failure treatment

Sep. 16, 2021—Researchers at Vanderbilt have been awarded a five-year, $4 million federal grant to test whether a personalized medicine strategy will improve outcomes for patients hospitalized with acute heart failure.

Read more


Medical diagnoses in musicians

Sep. 6, 2021—Vanderbilt researchers mined electronic health records to find medical diagnoses that are more or less prevalent among musicians, who are present in large numbers in “Music City.”

Read more


Study underscores importance of personalized medicine in kidney cancer

Nov. 10, 2020—A new study sheds light on how molecular subsets within the tumors of kidney cancer patients determine treatment outcomes and underscores the importance of personalized medicine in making therapy decisions.

Read more


All of Us program launches cloud-based research platform

Jun. 18, 2020—On May 27, the All of Us Research Program launched the beta version of its cloud-based research platform, the Researcher Workbench.

Read more


Robotic technology speeds arrhythmia gene classification

Jun. 12, 2020—Vanderbilt University Medical Center investigators have used high-throughput robotic technology to rapidly study and classify variations in a gene linked to heart rhythm disorders and cardiac conditions.

Read more


VUMC’s Denny selected to lead national ‘All of Us’ program

Dec. 11, 2019—The National Institutes of Health (NIH) has selected Joshua Denny, MD, MS, vice president of Personalized Medicine at Vanderbilt University Medical Center, to be the chief executive officer of the federal All of Us Research Program.

Read more


Roden wins Schottenstein Prize from Ohio State University

Nov. 18, 2019—  by Bill Snyder Dan Roden, MD, Senior Vice President for Personalized Medicine at Vanderbilt University Medical Center, has been awarded the 2019 Jay and Jeanie Schottenstein Prize in Cardiovascular Sciences by The Ohio State University Wexner Medical Center’s Heart and Vascular Center, Ohio State officials announced Nov. 18. Awarded biennially, the Schottenstein Prize honors...

Read more


NCI ‘Moonshot’ grant to boost hereditary cancer identification

Nov. 14, 2019—VUMC is leading an initiative to establish a streamlined process for collection of family health histories that could set the stage for a standardized system to make the information easily accessible.

Read more


Article examines need for genotyping after stenting

Oct. 24, 2019—Genotyping can improve outcomes in patients who require anti-platelet therapy following stent placement to open narrowed or blocked coronary arteries and prevent a heart attack.

Read more


Peterson, Roden honored for translational medicine efforts

Oct. 17, 2019—Josh Peterson, MD, MPH, and Dan Roden, MD, are among 10 leaders in clinical pharmacology and translational medicine recognized this week by the American Society for Clinical Pharmacology and Therapeutics.

Read more


New test assists physicians with quicker treatment decisions for sepsis

Oct. 3, 2019—Rapid blood culture diagnostics for patients with bacterial bloodstream infections delivered final results in 12 hours versus the two to three days required for conventional testing.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more